<html xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns="http://www.w3.org/TR/REC-html40">


<!-- Mirrored from medicain.net/DUOC THU QUOC GIA/Vinblastin.htm by HTTrack Website Copier/3.x [XR&CO'2013], Tue, 25 Mar 2014 18:07:14 GMT -->
<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 11">
<meta name=Originator content="Microsoft Word 11">
<link rel=File-List href="javascript:if(confirm('http://www.vietstarse.com/duocthu/Documents/Vinblastin_files/filelist.xml  \n\nThis file was not retrieved by Teleport Pro, because the server reports that this file cannot be found.  \n\nDo you want to open it from the server?'))window.location='http://www.vietstarse.com/duocthu/Documents/Vinblastin_files/filelist.xml'" tppabs="http://www.vietstarse.com/duocthu/Documents/Vinblastin_files/filelist.xml">
<title>VINBLASTIN</title>
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>VIETSTAR</o:Author>
  <o:LastAuthor>Ghost</o:LastAuthor>
  <o:Revision>3</o:Revision>
  <o:TotalTime>1</o:TotalTime>
  <o:Created>2006-08-08T14:11:00Z</o:Created>
  <o:LastSaved>2006-08-08T14:31:00Z</o:LastSaved>
  <o:Pages>2</o:Pages>
  <o:Words>1390</o:Words>
  <o:Characters>7924</o:Characters>
  <o:Company>VS</o:Company>
  <o:Lines>66</o:Lines>
  <o:Paragraphs>18</o:Paragraphs>
  <o:CharactersWithSpaces>9296</o:CharactersWithSpaces>
  <o:Version>11.5606</o:Version>
 </o:DocumentProperties>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:DoNotHyphenateCaps/>
  <w:PunctuationKerning/>
  <w:ValidateAgainstSchemas>false</w:ValidateAgainstSchemas>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:DoNotUnderlineInvalidXML/>
  <w:Compatibility>
   <w:SelectEntireFieldWithStartOrEnd/>
   <w:UseWord2002TableStyleRules/>
  </w:Compatibility>
  <w:BrowserLevel>MicrosoftInternetExplorer4</w:BrowserLevel>
 </w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:LatentStyles DefLockedState="false" LatentStyleCount="156">
 </w:LatentStyles>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:1627421319 -2147483648 8 0 66047 0;}
@font-face
	{font-family:Verdana;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:536871559 0 0 0 415 0;}
@font-face
	{font-family:TahomaH;
	panose-1:0 0 0 0 0 0 0 0 0 0;
	mso-font-alt:Arial;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-format:other;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-parent:"";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
h1
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:1;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-font-kerning:0pt;}
h2
	{mso-style-next:Normal;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:9.0pt;
	font-family:Tahoma;}
h3
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-line-height-alt:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:3;
	layout-grid-mode:char;
	font-size:14.0pt;
	font-family:Tahoma;
	font-weight:normal;
	font-style:italic;}
h4
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:4;
	font-size:9.0pt;
	font-family:Tahoma;
	font-weight:normal;}
h5
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:5;
	font-size:9.0pt;
	font-family:Tahoma;}
h6
	{mso-style-next:Normal;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.3pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:6;
	font-size:9.0pt;
	font-family:Tahoma;
	font-style:italic;}
p.MsoHeading7, li.MsoHeading7, div.MsoHeading7
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:7;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
p.MsoHeading8, li.MsoHeading8, div.MsoHeading8
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:8;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.MsoHeading9, li.MsoHeading9, div.MsoHeading9
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:9;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.MsoFootnoteText, li.MsoFootnoteText, div.MsoFootnoteText
	{mso-style-noshow:yes;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	tab-stops:right 411.1pt;
	border:none;
	mso-border-bottom-alt:solid windowtext .5pt;
	padding:0in;
	mso-padding-alt:0in 0in 1.0pt 0in;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	tab-stops:center 3.0in right 6.0in;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoCaption, li.MsoCaption, div.MsoCaption
	{mso-style-noshow:yes;
	mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
span.MsoFootnoteReference
	{mso-style-noshow:yes;
	vertical-align:super;}
span.MsoCommentReference
	{mso-style-noshow:yes;
	mso-ansi-font-size:8.0pt;
	mso-bidi-font-size:8.0pt;}
span.MsoPageNumber
	{mso-ansi-font-size:9.0pt;
	mso-bidi-font-size:9.0pt;
	font-family:Tahoma;
	mso-ascii-font-family:Tahoma;
	mso-hansi-font-family:Tahoma;
	mso-bidi-font-family:Tahoma;}
p.MsoTitle, li.MsoTitle, div.MsoTitle
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:TahomaH;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:TahomaH;
	font-weight:bold;}
p.MsoBodyText, li.MsoBodyText, div.MsoBodyText
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyText2, li.MsoBodyText2, div.MsoBodyText2
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:2.0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-2.0in;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyText3, li.MsoBodyText3, div.MsoBodyText3
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyTextIndent2, li.MsoBodyTextIndent2, div.MsoBodyTextIndent2
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:14.2pt;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
p.MsoBodyTextIndent3, li.MsoBodyTextIndent3, div.MsoBodyTextIndent3
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:56.7pt;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-14.15pt;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	mso-layout-grid-align:none;
	punctuation-wrap:simple;
	text-autospace:none;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoDocumentMap, li.MsoDocumentMap, div.MsoDocumentMap
	{mso-style-noshow:yes;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	background:navy;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.1, li.1, div.1
	{mso-style-name:1;
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	text-align:center;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.1nho, li.1nho, div.1nho
	{mso-style-name:1nho;
	margin-top:3.5pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.2, li.2, div.2
	{mso-style-name:2;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:8.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.3, li.3, div.3
	{mso-style-name:3;
	mso-style-parent:2;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.5, li.5, div.5
	{mso-style-name:5;
	mso-style-parent:2;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:8.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
p.bai, li.bai, div.bai
	{mso-style-name:bai;
	mso-style-parent:"Heading 2";
	margin-top:25.0pt;
	margin-right:0in;
	margin-bottom:10.0pt;
	margin-left:0in;
	text-align:center;
	line-height:10.4pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.BodyText21, li.BodyText21, div.BodyText21
	{mso-style-name:"Body Text 21";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-line-height-alt:10.5pt;
	mso-pagination:widow-orphan;
	font-size:14.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.cach0, li.cach0, div.cach0
	{mso-style-name:"cach0\,4";
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.chucach, li.chucach, div.chucach
	{mso-style-name:chucach;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.normal1, li.normal1, div.normal1
	{mso-style-name:normal1;
	mso-style-parent:"cach0\,4";
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.Style1, li.Style1, div.Style1
	{mso-style-name:Style1;
	mso-style-parent:"Heading 2";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:48.2pt;
	text-align:justify;
	text-indent:-17.0pt;
	line-height:150%;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	tab-stops:list 49.2pt;
	font-size:14.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;
	text-decoration:underline;
	text-underline:single;}
@page Section1
	{size:8.5in 11.0in;
	margin:1.0in 1.25in 1.0in 1.25in;
	mso-header-margin:.5in;
	mso-footer-margin:.5in;
	mso-paper-source:0;}
div.Section1
	{page:Section1;}
-->
</style>
<!--[if gte mso 10]>
<style>
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-parent:"";
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin:0in;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman";
	mso-ansi-language:#0400;
	mso-fareast-language:#0400;
	mso-bidi-language:#0400;}
</style>
<![endif]-->
</head>

<body lang=EN-US style='tab-interval:.5in'>

<div class=Section1>

<h1 align=center style='text-align:center;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:15.0pt;line-height:150%;font-family:
Verdana'>VINBLASTIN<o:p></o:p></span></h1>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'><o:p>&nbsp;</o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><b><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Tên chung qu&#7889;c t&#7871;: </span></b><span style='font-size:9.0pt;
mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Vinblastine.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><b><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Mã ATC: </span></b><span style='font-size:9.0pt;mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>L01C A01.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><b><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Lo&#7841;i thu&#7889;c: </span></b><span style='font-size:9.0pt;
mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Thu&#7889;c ch&#7889;ng
ung th&#432;.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><b><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;letter-spacing:-.1pt'>D&#7841;ng thu&#7889;c và hàm l&#432;&#7907;ng: </span></b><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;letter-spacing:-.1pt'>&#7889;ng tiêm vinblastin sulfat hàm l&#432;&#7907;ng
10 mg/ml.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>D&#432;&#7907;c lý và c&#417; ch&#7871;
tác d&#7909;ng<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Vinblastin là m&#7897;t alcaloid chi&#7871;t xu&#7845;t t&#7915; cây D&#7915;a
c&#7841;n <i>Catharanthus roseus</i> (L.) G. Don có tác d&#7909;ng ch&#7889;ng
ung th&#432;. M&#7863;c dù c&#417; ch&#7871; tác d&#7909;ng c&#7911;a thu&#7889;c
còn ch&#432;a th&#7853;t sáng t&#7887;, nh&#432;ng có l&#7869; vinblastin th&#7875;
hi&#7879;n tác d&#7909;ng &#273;&#7897;c t&#7871; bào b&#7857;ng cách &#7913;c
ch&#7871; s&#7921; t&#7841;o thành các vi &#7889;ng trên thoi gián phân d&#7851;n
t&#7899;i ng&#7915;ng phân chia t&#7871; bào &#7903; pha gi&#7919;a (pha M). &#7902;
n&#7891;ng &#273;&#7897; cao, vinblastin còn th&#7875; hi&#7879;n nhi&#7873;u
tác d&#7909;ng ph&#7913;c t&#7841;p trên t&#7893;ng h&#7907;p acid nucleic và
protein.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Sau khi tiêm t&#297;nh m&#7841;ch, vinblastin sulfat nhanh chóng phân
b&#7889; vào các mô c&#7911;a c&#417; th&#7875;. Thu&#7889;c liên k&#7871;t nhi&#7873;u
v&#7899;i protein (75%). Vinblastin ít qua hàng rào máu - não và không &#273;&#7841;t
n&#7891;ng &#273;&#7897; &#273;i&#7873;u tr&#7883; trong d&#7883;ch não t&#7911;y.
Vinblastin &#273;&#432;&#7907;c chuy&#7875;n hóa nhi&#7873;u, ch&#7911; y&#7871;u
&#7903; gan &#273;&#7875; thành desacetyl vinblastin là ch&#7845;t có ho&#7841;t
tính m&#7841;nh h&#417;n vinblastin, tính trên c&#417; s&#7903; cùng kh&#7889;i
l&#432;&#7907;ng. Thu&#7889;c &#273;ào th&#7843;i qua m&#7853;t vào phân và vào
n&#432;&#7899;c ti&#7875;u, m&#7897;t s&#7889; &#273;ào th&#7843;i d&#432;&#7899;i
d&#7841;ng thu&#7889;c không bi&#7871;n &#273;&#7893;i. <b><o:p></o:p></b></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Ch&#7881; &#273;&#7883;nh<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Vinblastin &#273;&#432;&#7907;c s&#7917; d&#7909;ng &#273;&#417;n
&#273;&#7897;c và ph&#7889;i h&#7907;p v&#7899;i các thu&#7889;c khác trong
&#273;i&#7873;u tr&#7883; ung th&#432;:<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ung th&#432; th&#432;&#7901;ng &#273;áp &#7913;ng v&#7899;i thu&#7889;c:
B&#7879;nh Hodgkin (giai &#273;o&#7841;n III và IV); u lympho không Hodgkin;
lympho mô bào (u lympho mô bào); ung th&#432; tinh hoàn; u sùi d&#7841;ng n&#7845;m;
sarcom Kaposi; b&#7879;nh Letterer - Siwe.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ung th&#432; kém &#273;áp &#7913;ng v&#7899;i thu&#7889;c h&#417;n:
Ung th&#432; nhau kháng các thu&#7889;c hóa tr&#7883; li&#7879;u khác; Ung th&#432;
bi&#7875;u mô vú không &#273;áp &#7913;ng v&#7899;i ph&#7851;u thu&#7853;t và
li&#7879;u pháp hormon thích h&#7907;p.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Ch&#7889;ng ch&#7881; &#273;&#7883;nh<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ch&#7889;ng ch&#7881; &#273;&#7883;nh dùng vinblastin cho các ng&#432;&#7901;i
b&#7879;nh gi&#7843;m b&#7841;ch c&#7847;u h&#7841;t rõ r&#7879;t, tr&#7915;
phi &#273;ó là k&#7871;t qu&#7843; c&#7911;a b&#7879;nh &#273;ang &#273;&#432;&#7907;c
&#273;i&#7873;u tr&#7883; <o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Không &#273;&#432;&#7907;c dùng vinblastin trong tr&#432;&#7901;ng h&#7907;p
ng&#432;&#7901;i b&#7879;nh b&#7883; nhi&#7877;m khu&#7849;n. N&#7871;u có nhi&#7877;m
khu&#7849;n ph&#7843;i &#273;&#432;&#7907;c &#273;i&#7873;u tr&#7883; tr&#432;&#7899;c
khi b&#7855;t &#273;&#7847;u &#273;i&#7873;u tr&#7883; b&#7857;ng vinblastin.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Th&#7853;n tr&#7885;ng<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Vinblastin sulfat gây kích &#7913;ng r&#7845;t m&#7841;nh. Thu&#7889;c
ch&#7881; &#273;&#432;&#7907;c tiêm t&#297;nh m&#7841;ch b&#7903;i ng&#432;&#7901;i
có kinh nghi&#7879;m tiêm thu&#7889;c; thu&#7889;c không &#273;&#432;&#7907;c
tiêm b&#7855;p, d&#432;&#7899;i da ho&#7863;c trong màng não t&#7911;y. Tiêm
trong màng não t&#7911;y &#273;ã gây t&#7917; vong.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Vinblastin sulfat là m&#7897;t thu&#7889;c có &#273;&#7897;c tính cao
và ch&#7881; s&#7889; &#273;i&#7873;u tr&#7883; th&#7845;p. Thu&#7889;c ph&#7843;i
&#273;&#432;&#7907;c s&#7917; d&#7909;ng d&#432;&#7899;i s&#7921; giám sát
th&#432;&#7901;ng xuyên c&#7911;a th&#7847;y thu&#7889;c có kinh nghi&#7879;m
trong &#273;i&#7873;u tr&#7883; b&#7857;ng các thu&#7889;c &#273;&#7897;c t&#7871;
bào.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ng&#432;&#7901;i b&#7879;nh suy mòn ho&#7863;c có nh&#7919;ng vùng
loét trên da có th&#7875; d&#7877; b&#7883; &#7843;nh h&#432;&#7903;ng b&#7903;i
tác d&#7909;ng h&#7841; b&#7841;ch c&#7847;u c&#7911;a vinblastin. Vì v&#7853;y,
ph&#7843;i dùng thu&#7889;c h&#7871;t s&#7913;c th&#7853;n tr&#7885;ng cho
ng&#432;&#7901;i b&#7879;nh (&#273;&#7863;c bi&#7879;t là ng&#432;&#7901;i b&#7879;nh
cao tu&#7893;i) có nh&#7919;ng tình tr&#7841;ng b&#7879;nh nói trên.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ph&#7843;i làm công th&#7913;c máu hàng tu&#7847;n ho&#7863;c ít nh&#7845;t
là tr&#432;&#7899;c m&#7895;i li&#7873;u vinblastin. N&#7871;u s&#7889; l&#432;&#7907;ng
b&#7841;ch c&#7847;u gi&#7843;m xu&#7889;ng d&#432;&#7899;i 2000/mm<sup>3</sup>,
ng&#432;&#7901;i b&#7879;nh ph&#7843;i &#273;&#432;&#7907;c theo dõi c&#7849;n
th&#7853;n v&#7873; các d&#7845;u hi&#7879;u nhi&#7877;m khu&#7849;n cho t&#7899;i
khi s&#7889; l&#432;&#7907;ng b&#7841;ch c&#7847;u tr&#7903; l&#7841;i m&#7913;c
an toàn.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ph&#7843;i c&#7849;n th&#7853;n, tránh &#273;&#7875; các dung d&#7883;ch
vinblastin sulfat ti&#7871;p xúc v&#7899;i m&#7855;t vì giác m&#7841;c có th&#7875;
b&#7883; kích &#7913;ng n&#7863;ng ho&#7863;c loét; n&#7871;u có ti&#7871;p
xúc, ph&#7843;i r&#7917;a m&#7855;t ngay l&#7853;p t&#7913;c b&#7857;ng n&#432;&#7899;c.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Vì vinblastin chuy&#7875;n hóa qua gan và &#273;ào th&#7843;i &#7903;
m&#7853;t, c&#7847;n gi&#7843;m li&#7873;u cho ng&#432;&#7901;i b&#7879;nh vàng
da t&#7855;c m&#7853;t ho&#7863;c có th&#432;&#417;ng t&#7893;n t&#7871; bào
gan.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Th&#7901;i k&#7923; mang thai<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Khi dùng cho ng&#432;&#7901;i mang thai, vinblastin có th&#7875; gây
&#273;&#7897;c cho thai. Thu&#7889;c ch&#7881; &#273;&#432;&#7907;c dùng &#7903;
th&#7901;i k&#7923; mang thai khi tình tr&#7841;ng b&#7879;nh &#273;e d&#7885;a
tính m&#7841;ng ho&#7863;c b&#7879;nh n&#7863;ng mà các thu&#7889;c an toàn
h&#417;n không th&#7875; s&#7917; d&#7909;ng &#273;&#432;&#7907;c ho&#7863;c
không có hi&#7879;u l&#7921;c. C&#7847;n khuyên các ph&#7909; n&#7919; có kh&#7843;
n&#259;ng mang thai nên tránh có thai trong khi dùng vinblastin. Khi thu&#7889;c
này &#273;&#432;&#7907;c dùng trong th&#7901;i k&#7923; mang thai ho&#7863;c
ng&#432;&#7901;i b&#7879;nh th&#7909; thai trong khi dùng thu&#7889;c, thì c&#7847;n
thông báo cho ng&#432;&#7901;i b&#7879;nh bi&#7871;t v&#7873; ti&#7873;m
n&#259;ng nguy h&#7841;i &#273;&#7889;i v&#7899;i thai. <o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Th&#7901;i k&#7923; cho con bú<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Trong th&#7901;i gian &#273;i&#7873;u tr&#7883; vinblastin, nên ng&#7915;ng
cho con bú.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Tác d&#7909;ng không mong mu&#7889;n
(ADR)<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Nhi&#7873;u tác d&#7909;ng ph&#7909; c&#7911;a li&#7879;u pháp ch&#7889;ng
ung th&#432; là không th&#7875; tránh kh&#7887;i. M&#7897;t s&#7889; tác d&#7909;ng
này (thí d&#7909; gi&#7843;m b&#7841;ch c&#7847;u và gi&#7843;m ti&#7875;u c&#7847;u)
hi&#7879;n nay &#273;&#432;&#7907;c s&#7917; d&#7909;ng làm nh&#7919;ng thông s&#7889;
&#273;&#7875; giúp ch&#7881;nh li&#7873;u cho t&#7915;ng cá nhân. T&#7847;n su&#7845;t
các tác d&#7909;ng ph&#7909; th&#432;&#7901;ng liên quan &#273;&#7871;n li&#7873;u.<o:p></o:p></span></p>

<p class=5 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Th&#432;&#7901;ng g&#7863;p, ADR &gt; 1/100<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Toàn thân: M&#7879;t m&#7887;i, &#273;au b&#7909;ng, &#273;au chân,
chán &#259;n, &#273;au &#7903; nh&#7919;ng n&#417;i có kh&#7889;i u, &#273;au &#7903;
hàm.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Máu: Gi&#7843;m b&#7841;ch c&#7847;u h&#7841;t, thi&#7871;u máu, gi&#7843;m
ti&#7875;u c&#7847;u.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Tiêu hóa: Táo bón, bu&#7891;n nôn, nôn.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Da: R&#7909;ng tóc.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><i><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ít g&#7863;p, 1/1000 &lt; ADR &lt; 1/100 </span></i><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'><o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Toàn thân: Ðau &#273;&#7847;u.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Tim m&#7841;ch: T&#259;ng huy&#7871;t áp.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Tiêu hóa: Li&#7879;t ru&#7897;t, viêm mi&#7879;ng, viêm h&#7885;ng.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Th&#7847;n kinh: B&#7879;nh lý th&#7847;n kinh ngo&#7841;i vi, m&#7845;t
ph&#7843;n x&#7841; gân sâu.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><i><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Hi&#7871;m g&#7863;p, ADR &lt; 1/1000</span></i><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'><o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Tiêu hóa: Viêm ti&#7875;u - k&#7871;t tràng ch&#7843;y máu.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Th&#7847;n kinh: Co gi&#7853;t.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>H&#432;&#7899;ng d&#7851;n cách x&#7917;
trí ADR<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Tác d&#7909;ng không mong mu&#7889;n ch&#7911; y&#7871;u c&#7911;a
vinblastin là &#273;&#7897;c tính huy&#7871;t h&#7885;c. Gi&#7843;m b&#7841;ch
c&#7847;u (gi&#7843;m b&#7841;ch c&#7847;u h&#7841;t) x&#7843;y ra ph&#7893; bi&#7871;n
nh&#7845;t và th&#432;&#7901;ng là y&#7871;u t&#7889; gi&#7899;i h&#7841;n li&#7873;u
trong &#273;i&#7873;u tr&#7883; b&#7857;ng vinblastin. Gi&#7843;m b&#7841;ch c&#7847;u
có th&#7875; không thành v&#7845;n &#273;&#7873; khi dùng li&#7873;u th&#7845;p
trong &#273;i&#7873;u tr&#7883; duy trì; tuy nhiên kh&#7843; n&#259;ng tích l&#361;y
tác d&#7909;ng c&#7847;n &#273;&#432;&#7907;c quan tâm. S&#7889; l&#432;&#7907;ng
b&#7841;ch c&#7847;u th&#432;&#7901;ng xu&#7889;ng th&#7845;p nh&#7845;t 4 - 10
ngày sau ngày cu&#7889;i cùng dùng vinblastin và tr&#7903; l&#7841;i nhanh
trong vòng 7 - 14 ngày ti&#7871;p sau. C&#7847;n ph&#7843;i theo dõi c&#7849;n
th&#7853;n tình tr&#7841;ng huy&#7871;t h&#7885;c c&#7911;a ng&#432;&#7901;i b&#7879;nh.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ng&#432;&#7901;i b&#7879;nh gi&#7843;m b&#7841;ch c&#7847;u c&#7847;n
&#273;&#432;&#7907;c theo dõi ch&#7863;t ch&#7869; v&#7873; d&#7845;u hi&#7879;u
nhi&#7877;m khu&#7849;n. Có th&#7875; ph&#7843;i dùng kháng sinh &#273;&#7875;
h&#7895; tr&#7907;. &#7902; ng&#432;&#7901;i b&#7879;nh gi&#7843;m b&#7841;ch c&#7847;u
trung tính b&#7883; s&#7889;t, kh&#7903;i &#273;&#7847;u nên dùng kháng sinh ph&#7893;
r&#7897;ng, trong khi ch&#7901; &#273;&#7907;i nuôi c&#7845;y vi khu&#7849;n và
các xét nghi&#7879;m ch&#7849;n &#273;oán thích h&#7907;p.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Tác d&#7909;ng suy t&#7911;y x&#432;&#417;ng c&#7911;a vinblastin có
th&#7875; d&#7851;n &#273;&#7871;n t&#259;ng t&#7927; l&#7879; nhi&#7877;m khu&#7849;n,
ch&#7853;m lành b&#7879;nh và ch&#7843;y máu l&#7907;i. Ng&#432;&#7901;i b&#7879;nh
ph&#7843;i &#273;&#432;&#7907;c h&#432;&#7899;ng d&#7851;n gi&#7919; v&#7879;
sinh mi&#7879;ng trong th&#7901;i gian &#273;i&#7873;u tr&#7883;.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Bu&#7891;n nôn và nôn th&#432;&#7901;ng không quá 24 gi&#7901; và d&#7877;
dàng ki&#7875;m soát b&#7857;ng thu&#7889;c ch&#7889;ng nôn.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Vinblastin kích &#7913;ng mô và có th&#7875; gây viêm t&#297;nh m&#7841;ch
và ho&#7841;i t&#7917;. Tiêm thu&#7889;c ra ngoài m&#7841;ch máu có th&#7875;
gây &#273;au và viêm mô t&#7871; bào. Ph&#7843;n &#7913;ng t&#7841;i ch&#7895;
có th&#7875; n&#7863;ng và kéo dài nhi&#7873;u tu&#7847;n &#273;&#7871;n hàng
tháng. Tiêm t&#7841;i ch&#7895; hyaluronidase và ch&#432;&#7901;m nóng v&#7915;a
ph&#7843;i có th&#7875; làm gi&#7843;m &#273;&#432;&#7907;c các ph&#7843;n &#7913;ng
t&#7841;i ch&#7895; do tiêm thu&#7889;c ra ngoài m&#7841;ch. Tuy v&#7853;y m&#7897;t
s&#7889; th&#7847;y thu&#7889;c &#432;a &#273;i&#7873;u tr&#7883; thoát m&#7841;ch
b&#7857;ng &#273;&#7855;p g&#7841;c l&#7841;nh, tiêm dung d&#7883;ch natri
clorid 0,9% &#273;&#7875; pha loãng và/ho&#7863;c tiêm hydrocortison t&#7841;i
ch&#7895;.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Li&#7873;u l&#432;&#7907;ng và
cách dùng<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Li&#7873;u dùng vinblastin cho ng&#432;&#7901;i l&#7899;n khi b&#7855;t
&#273;&#7847;u &#273;i&#7873;u tr&#7883; th&#432;&#7901;ng là 3,7 mg/m<sup>2</sup>
di&#7879;n tích c&#417; th&#7875;, tiêm t&#297;nh m&#7841;ch m&#7897;t l&#7847;n.
Li&#7873;u thông th&#432;&#7901;ng b&#7855;t &#273;&#7847;u cho tr&#7867; em là
2,5 mg/m<sup>2</sup>, tiêm t&#297;nh m&#7841;ch m&#7897;t l&#7847;n. V&#7899;i
ng&#432;&#7901;i b&#7879;nh có bilirubin huy&#7871;t tr&#7921;c ti&#7871;p
v&#432;&#7907;t quá 3 mg/decilít, thì nên gi&#7843;m 50% li&#7873;u. Li&#7873;u
ti&#7871;p sau ph&#7843;i c&#259;n c&#7913; vào &#273;áp &#7913;ng lâm sàng,
huy&#7871;t h&#7885;c và vào &#273;&#7897; dung n&#7841;p c&#7911;a ng&#432;&#7901;i
b&#7879;nh &#273;&#7875; xác &#273;&#7883;nh, nh&#7857;m &#273;&#7841;t k&#7871;t
qu&#7843; &#273;i&#7873;u tr&#7883; t&#7889;i &#432;u v&#7899;i tác d&#7909;ng
ph&#7909; t&#7889;i thi&#7875;u. Sau khi dùng <span style='letter-spacing:-.1pt'>thu&#7889;c,
có th&#7875; có gi&#7843;m b&#7841;ch c&#7847;u, vì v&#7853;y dùng thu&#7889;c
ph&#7843;i cách nhau ít nh&#7845;t 7 ngày. Tuy nhiên, dù &#273;ã quá 7 ngày, v&#7851;n
không dùng li&#7873;u vinblastin ti&#7871;p sau cho t&#7899;i khi nào s&#7889;
l&#432;&#7907;ng b&#7841;ch c&#7847;u tr&#7903; l&#7841;i ít nh&#7845;t là
4000/mm<sup>3</sup>. Th&#432;&#7901;ng c&#7913; m&#7895;i tu&#7847;n t&#259;ng
li&#7873;u dùng thêm lên kho&#7843;ng 1,8 mg/m<sup>2</sup> cho ng&#432;&#7901;i
l&#7899;n ho&#7863;c 1,25 mg/m<sup>2</sup> cho tr&#7867; em, cho t&#7899;i khi
&#273;&#7841;t &#273;áp &#7913;ng &#273;i&#7873;u tr&#7883; mong mu&#7889;n
(thí d&#7909; gi&#7843;m kích th&#432;&#7899;c kh&#7889;i u), khi s&#7889;
l&#432;&#7907;ng b&#7841;ch c&#7847;u gi&#7843;m xu&#7889;ng còn kho&#7843;ng
3000/mm<sup>3</sup>, ho&#7863;c khi &#273;ã dùng t&#7899;i li&#7873;u t&#7889;i
&#273;a hàng tu&#7847;n 18,5 mg/m<sup>2</sup> cho ng&#432;&#7901;i l&#7899;n ho&#7863;c
12,5 mg/m<sup>2</sup> cho tr&#7867; em. V&#7899;i &#273;a s&#7889; ng&#432;&#7901;i
b&#7879;nh là ng&#432;&#7901;i l&#7899;n, li&#7873;u t&#7889;i &#432;u hàng tu&#7847;n
th&#432;&#7901;ng là 5,5 - 7,4 mg/m<sup>2</sup>; tuy nhiên gi&#7843;m b&#7841;ch
c&#7847;u (s&#7889; l&#432;&#7907;ng b&#7841;ch c&#7847;u kho&#7843;ng 3000/mm<sup>3</sup>)
có th&#7875; x&#7843;y ra ngay c&#7843; &#7903; m&#7897;t s&#7889; ng&#432;&#7901;i
b&#7879;nh dùng li&#7873;u 3,7</span> mg/m<sup>2</sup> m&#7895;i tu&#7847;n,
còn m&#7897;t s&#7889; ng&#432;&#7901;i b&#7879;nh khác thì có th&#7875; dung n&#7841;p
t&#7899;i 18,5 mg/m<sup>2</sup> m&#7895;i tu&#7847;n. Th&#432;&#7901;ng nên gi&#7843;m
li&#7873;u cho ng&#432;&#7901;i b&#7879;nh m&#7899;i &#273;i&#7873;u tr&#7883;
tia x&#7841; ho&#7863;c hóa tr&#7883; li&#7879;u; li&#7873;u &#273;&#417;n c&#7911;a
nh&#7919;ng ng&#432;&#7901;i b&#7879;nh này th&#432;&#7901;ng không v&#432;&#7907;t
quá 5,5 mg/m<sup>2</sup>. M&#7897;t khi &#273;ã xác &#273;&#7883;nh
&#273;&#432;&#7907;c li&#7873;u gây gi&#7843;m b&#7841;ch c&#7847;u xu&#7889;ng
còn 3000/mm<sup>3</sup>, thì dùng li&#7873;u duy trì m&#7895;i tu&#7847;n 1 l&#7847;n
cho ng&#432;&#7901;i l&#7899;n th&#7845;p h&#417;n kho&#7843;ng 1,8 mg/m<sup>2</sup>
so v&#7899;i li&#7873;u nói trên, và th&#7845;p h&#417;n kho&#7843;ng 1,25 mg/m<sup>2</sup>
&#273;&#7889;i v&#7899;i tr&#7867; em. Nh&#432; v&#7853;y là ng&#432;&#7901;i b&#7879;nh
&#273;ã &#273;&#432;&#7907;c dùng li&#7873;u vinblastin t&#7889;i &#273;a không
gây gi&#7843;m b&#7841;ch c&#7847;u. Ði&#7873;u tr&#7883; vinblastin ph&#7843;i
ti&#7871;p t&#7909;c ít nh&#7845;t 4 - 6 tu&#7847;n, m&#7897;t s&#7889;
ng&#432;&#7901;i b&#7879;nh, nh&#7845;t là ng&#432;&#7901;i m&#7855;c
carcinoma, ph&#7843;i c&#7847;n t&#7899;i 12 tu&#7847;n.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>T&#432;&#417;ng tác thu&#7889;c<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Khi dùng vinblastin cùng v&#7899;i phenytoin, n&#7891;ng &#273;&#7897;
phenytoin trong huy&#7871;t thanh b&#7883; gi&#7843;m, có l&#7869; do gi&#7843;m
h&#7845;p thu và t&#259;ng chuy&#7875;n hóa c&#7911;a phenytoin. Do &#273;ó c&#7847;n
ph&#7843;i &#273;i&#7873;u ch&#7881;nh li&#7873;u l&#432;&#7907;ng phenytoin.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Vinblastin &#273;&#432;&#7907;c chuy&#7875;n hóa b&#7903;i isoenzym
CYP3A c&#7911;a cytochrom P<sub>450</sub>. Dùng vinblastin cùng v&#7899;i các
thu&#7889;c &#7913;c ch&#7871; m&#7841;nh isoenzym này, chuy&#7875;n hóa c&#7911;a
vinblastin có th&#7875; b&#7883; &#7913;c ch&#7871;, d&#7851;n &#273;&#7871;n
xu&#7845;t hi&#7879;n s&#7899;m ho&#7863;c t&#259;ng m&#7913;c &#273;&#7897; n&#7863;ng
c&#7911;a các tác d&#7909;ng ph&#7909; c&#7911;a thu&#7889;c.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Ð&#7897; &#7893;n &#273;&#7883;nh
và b&#7843;o qu&#7843;n<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>B&#7843;o qu&#7843;n &#7903; nhi&#7879;t &#273;&#7897; 4 - 8<sup>0</sup>C,
tránh ánh sáng.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>T&#432;&#417;ng k&#7925;<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>N&#7871;u tr&#7897;n vinblastin cùng v&#7899;i furosemid trong cùng
dây truy&#7873;n ho&#7863;c b&#417;m tiêm s&#7869; gây k&#7871;t t&#7911;a ngay
l&#7853;p t&#7913;c.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Quá li&#7873;u và x&#7917; trí<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Tác d&#7909;ng không mong mu&#7889;n c&#7911;a vinblastin ph&#7909;
thu&#7897;c li&#7873;u. Vì v&#7853;y n&#7871;u tiêm li&#7873;u cao h&#417;n li&#7873;u
&#273;&#432;&#7907;c khuy&#7871;n cáo, ng&#432;&#7901;i b&#7879;nh có th&#7875;
b&#7883; nh&#7919;ng ph&#7843;n &#7913;ng không mong mu&#7889;n nói trên m&#7897;t
cách quá m&#7913;c. Không có thu&#7889;c gi&#7843;i &#273;&#7897;c &#273;&#7863;c
hi&#7879;u. Vì vinblastin bài xu&#7845;t ch&#7911; y&#7871;u qua gan - m&#7853;t,
nên &#273;&#7897;c tính c&#7911;a thu&#7889;c có th&#7875; t&#259;ng khi b&#7883;
suy gan. Vi&#7879;c ch&#259;m sóc h&#7895; tr&#7907; khi quá li&#7873;u bao g&#7891;m:
Theo dõi tim m&#7841;ch, dùng thu&#7889;c ch&#7889;ng co gi&#7853;t, phòng ng&#7915;a
t&#7855;c ru&#7897;t, xét nghi&#7879;m &#273;&#7871;m máu hàng ngày &#273;&#7875;
xác &#273;&#7883;nh yêu c&#7847;u truy&#7873;n máu và &#273;&#7875; &#273;ánh
giá nguy c&#417; nhi&#7877;m khu&#7849;n. Tác d&#7909;ng ch&#7911; y&#7871;u c&#7911;a
quá li&#7873;u vinblastin là suy t&#7911;y x&#432;&#417;ng có th&#7875; &#273;e
d&#7885;a tính m&#7841;ng. Không có thông tin v&#7873; hi&#7879;u qu&#7843; c&#7911;a
th&#7849;m phân ho&#7863;c c&#7911;a cholestyramin trong &#273;i&#7873;u tr&#7883;
quá li&#7873;u.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Thông tin qui ch&#7871;<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Vinblastin có trong danh m&#7909;c thu&#7889;c thi&#7871;t y&#7871;u
Vi&#7879;t Nam ban hành l&#7847;n th&#7913; t&#432; n&#259;m 1999.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Thu&#7889;c &#273;&#7897;c b&#7843;ng A.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'><o:p>&nbsp;</o:p></span></p>

</div>

</body>


<!-- Mirrored from medicain.net/DUOC THU QUOC GIA/Vinblastin.htm by HTTrack Website Copier/3.x [XR&CO'2013], Tue, 25 Mar 2014 18:07:14 GMT -->
</html>
